Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Strategy Targets Lymphoma with Cancer-Specific Cell Death Inducers
December 2024
The new strategy converts CDKs into targeted activators of cancer-specific genes that promote cell death…
Read more
30 Oct 2024
Potential Survival Benefits of Transplant for TP53-Mutated Acute Myeloid Leukemia
A recent multicenter study led by researchers including Talha Badar and Moazzam Shahzad has highlighted the challenging prognosis of TP53-mutated acute myeloid leukemia.
30 Oct 2024
Low FOXP3+ Cell Count Linked to Poor Outcomes in Rare T Cell Lymphoma
Low levels of FOXP3+ regulatory T cells are associated with worse progression-free survival and more aggressive disease characteristics in patients with angioimmunoblastic T cell lymphoma.
27 Oct 2024
Optimal Treatment Strategies for Sjögren's Disease-Associated Lymphoma Revealed
A new study has highlighted the optimal treatment strategies for managing non-Hodgkin lymphoma in patients with Sjögren’s disease
26 Oct 2024
Study Reveals Mechanisms of Platelet FXIII-A Retention During Activation
A new study has revealed insights into the behaviour of platelet factor XIII-A, a major cytoplasmic protein, during platelet activation.
24 Oct 2024
Epigenetic Test May Predict Immunotherapy Success in Multiple Myeloma
Researchers have made a significant discovery that could one day help tailor immunotherapy treatments for patients with multiple myeloma.
18 Oct 2024
Blood Cancer Not Linked to Cognitive Decline in Older Adults
Older adults diagnosed with hematologic malignant neoplasms experience cognitive decline at a rate similar to normal aging.
18 Oct 2024
New CML Treatment Shows Promise, But Standard Therapy Endures
The ASC4FIRST trial highlights asciminib, a new BCR::ABL1 inhibitor, as a potential alternative to current tyrosine kinase inhibitors for chronic myeloid leukaemia
16 Oct 2024
Stroke Risk in Patients with Sickle Cell Disease
New research examining nearly three decades of data reveals a concerning rise in stroke rates among both children and adults with sickle cell disease
Loading posts...
« Previous
1
2
3
4
5
…
25
Next »